Xeltis

Series D+

Zurich, SwitzerlandFounded 2006Feb 2023

Xeltis raised €32M in a Series D+ round in Feb 2023. The company is based in Zurich, Switzerland. Investors in the round: DaVita Venture Group, EQT Life Sciences, Grand Pharma and 2 others. Data as of Nov 2026.

← Xeltis

Amount raised

€32M

€32,000,000

Native amount

32,000,000 EUR

Stage

Series D+

series d

Investors

Provenance & confidence

High confidence

Amount

Reported in EUR — no conversion. €32M

High confidence

Source

startupticker.ch · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

5 named

DaVita Venture Group EQT Life Sciences Grand Pharma international investors Invest-NL

Date

Feb 2023

Round type

series d

Amount (EUR)

€32M

Other rounds

same company

Xeltis

Provenance & confidence

Investors in this round

Other rounds

Related news